Volume 22 (2023)
Volume 21 (2022)
Volume 20 (2021)
Volume 19 (2020)
Volume 18 (2019)
Volume 17 (2018)
Volume 16 (2017)
Volume 15 (2016)
Volume 14 (2015)
Volume 13 (2014)
Volume 12 (2013)
Volume 11 (2012)
Volume 10 (2011)
Low-dose versus standard-dose alteplase for intravenous thrombolysis in patients with acute ischemic stroke in Iran: Results from the safe implementation of treatments in stroke registry

Elyar Sadeghi-Hokmabadi; Abdoreza Ghoreishi; Reza Rikhtegar; Payam Sariaslani; Shahram Rafie; Alireza Vakilian; Ehsan Sharifipour; Masoud Mehrpour; Mohammad Saadatnia; Mohammad Mirza-Aghazadeh-Attari; Mehdi Farhoudi

Volume 20, Issue 4 , October 2021, , Pages 208-213


  Background: Rates of intracranial hemorrhage (ICH) after intravenous thrombolysis (IVT) differ depending on ethnicity, one reason that few Eastern countries have approved a lower dose of alteplase. Data in this regard are scarce in the Middle Eastern region. Methods: The present retrospective study ...  Read More

A survey from Turkey and Iran on comparison of risk factors and etiology in ischemic stroke

Gulcin Benbir Senel; Ayse Deniz Elmali; Kaveh Mehrvar; Mehdi Farhoudi; Mohammad Aboutalebi; Mahsa Rezaei; Birsen Ince

Volume 18, Issue 4 , December 2019, , Pages 176-178

  Background: Multiple sclerosis (MS) is a neurologic disorder with a considerable global burden. During the last decades, some pharmaceutical treatments have been approved for patients with MS. Dimethyl fumarate (DMF) is one of these drugs which has been reported to have early promising results in recent ...  Read More

Prognostic factors in patients with acute ischemic stroke treated with intravenous tissue plasminogen activator: The first study among Iranian patients

Elyar Sadeghi-Hokmabadi; Mohammad Yazdchi; Mehdi Farhoudi; Homayoun Sadeghi; Aliakbar Taheraghdam; Reza Rikhtegar; Sahar Mohammadi-Fallah; Rogayyeh Asadi; Elham Mehdizadeh-Far; Neda Ghaemian

Volume 17, Issue 1 , January 2018, , Pages 31-37

  Background: Tissue plasminogen activator (tPA) has been long approved as an efficacious treatment in patients with acute ischemic stroke (AIS); however, due to some serious complications, particularly intracranial hemorrhage (ICH), many physicians are still reluctant to use it liberally. This study sought ...  Read More

The efficacy of the ketogenic diet on motor functions in Parkinson’s disease: A rat ‎model

Sheida Shaafi; Safa Najmi; Hamed Aliasgharpour; Javad Mahmoudi; Saeed Sadigh-Etemad; Mahdi Farhoudi; Negar Baniasadi

Volume 15, Issue 2 , April 2016, , Pages 63-69

  Background: The ketogenic diet (KD), high in fat and low in carbohydrate and protein, provides sufficient protein but insufficient carbohydrates for all the metabolic needs of the body. KD has been known as a therapeutic manner intractable epilepsy. In recent years, the effectiveness of KD drew attention ...  Read More

Frequency of microembolic signals in patients with acute ischemic stroke in middle cerebral artery territory treated with aspirin or clopidogrel.

Mazyar Hashemilar; Mehdi Farhoudi; Samane Hosseini; Hanieh Moshayedi; Dariush Savadi Oskoui; Behzad Eskandar Oghli; Reza Rikhtegar

Volume 10, 1-2 , June 2011, , Pages 16-8

  Background: In patients with acute stroke and middle cerebral artery (MCA) stenosis, microembolic signals (MES) can predict further cerebral ischemia. Therefore, this study was designed to evaluate the prevalence of MES by transcranial Doppler (TCD) in patients with MCA stenosis under treatment of aspirin ...  Read More